Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy

Aims and Background The aim of the study was to evaluate the feasibility, toxicity and effectiveness of active breathing control-guided stereotactic body radiotherapy in the management of pulmonary oligometastases. Methods and Study Design Between June 2010 and June 2012, 20 patients (13 males, 7 fe...

Full description

Saved in:
Bibliographic Details
Published in:Tumori 2014-03, Vol.100 (2), p.179-183
Main Authors: Gamsiz, Hakan, Beyzadeoglu, Murat, Sager, Omer, Dincoglan, Ferrat, Demiral, Selcuk, Uysal, Bora, Surenkok, Serdar, Oysul, Kaan, Dirican, Bahar
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283
cites cdi_FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283
container_end_page 183
container_issue 2
container_start_page 179
container_title Tumori
container_volume 100
creator Gamsiz, Hakan
Beyzadeoglu, Murat
Sager, Omer
Dincoglan, Ferrat
Demiral, Selcuk
Uysal, Bora
Surenkok, Serdar
Oysul, Kaan
Dirican, Bahar
description Aims and Background The aim of the study was to evaluate the feasibility, toxicity and effectiveness of active breathing control-guided stereotactic body radiotherapy in the management of pulmonary oligometastases. Methods and Study Design Between June 2010 and June 2012, 20 patients (13 males, 7 females) with 31 pulmonary metastases referred to the Department of Radiation Oncology, Gulhane Military Medical Academy were treated using active breathing control-guided stereotactic body radiotherapy. Response Evaluation Criteria in Solid Tumors and Common Terminology Criteria for Adverse Events were used in the assessment of treatment response and toxicity, respectively. Results Assessment of treatment response revealed complete response, partial response, stable disease, and progressive disease in 30%, 25%, 30%, and 15% of the patients, respectively. At a median follow-up of 14 months, local control was 85% and overall survival was 70%, with negligible treatment-related toxicity. Conclusions Stereotactic body radiotherapy is safe and effective in the management of pulmonary oligometastases. It offers favorable treatment outcomes as a viable non-invasive therapeutic modality.
doi_str_mv 10.1177/030089161410000210
format article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_030089161410000210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_030089161410000210</sage_id><sourcerecordid>10.1177_030089161410000210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EEqHwA6z8A6Fj52FnCRWPSkVFPNaR7UxKqiSubHeRv8dR2SExGmk294zuvYTcMrhjTIglZACyYiXLGcThDM5IwiGTKS94dU6SWZDOikty5f0eIAdelglZv6pR7XDAMVDb0rdjP9hRuYlu-25nBwzKx0VP9UQ_Ajq0QZnQGfpgm4m-q6az4RudOkzX5KJVvceb37sgX0-Pn6uXdLN9Xq_uN6nhUoRUCC1YWXEjdVsVJssarnSrDGIuc2hAFrlqZIUy1zFGiSWCEFg0hQaoNJfZgvDTX-Os9w7b-uC6IVquGdRzGfXfMiK0PEE-hq339ujG6PE_4gf4OF-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy</title><source>Sage Journals Online</source><creator>Gamsiz, Hakan ; Beyzadeoglu, Murat ; Sager, Omer ; Dincoglan, Ferrat ; Demiral, Selcuk ; Uysal, Bora ; Surenkok, Serdar ; Oysul, Kaan ; Dirican, Bahar</creator><creatorcontrib>Gamsiz, Hakan ; Beyzadeoglu, Murat ; Sager, Omer ; Dincoglan, Ferrat ; Demiral, Selcuk ; Uysal, Bora ; Surenkok, Serdar ; Oysul, Kaan ; Dirican, Bahar</creatorcontrib><description>Aims and Background The aim of the study was to evaluate the feasibility, toxicity and effectiveness of active breathing control-guided stereotactic body radiotherapy in the management of pulmonary oligometastases. Methods and Study Design Between June 2010 and June 2012, 20 patients (13 males, 7 females) with 31 pulmonary metastases referred to the Department of Radiation Oncology, Gulhane Military Medical Academy were treated using active breathing control-guided stereotactic body radiotherapy. Response Evaluation Criteria in Solid Tumors and Common Terminology Criteria for Adverse Events were used in the assessment of treatment response and toxicity, respectively. Results Assessment of treatment response revealed complete response, partial response, stable disease, and progressive disease in 30%, 25%, 30%, and 15% of the patients, respectively. At a median follow-up of 14 months, local control was 85% and overall survival was 70%, with negligible treatment-related toxicity. Conclusions Stereotactic body radiotherapy is safe and effective in the management of pulmonary oligometastases. It offers favorable treatment outcomes as a viable non-invasive therapeutic modality.</description><identifier>ISSN: 0300-8916</identifier><identifier>EISSN: 2038-2529</identifier><identifier>DOI: 10.1177/030089161410000210</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>Tumori, 2014-03, Vol.100 (2), p.179-183</ispartof><rights>2014 SAGE Publications</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283</citedby><cites>FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904,79110</link.rule.ids></links><search><creatorcontrib>Gamsiz, Hakan</creatorcontrib><creatorcontrib>Beyzadeoglu, Murat</creatorcontrib><creatorcontrib>Sager, Omer</creatorcontrib><creatorcontrib>Dincoglan, Ferrat</creatorcontrib><creatorcontrib>Demiral, Selcuk</creatorcontrib><creatorcontrib>Uysal, Bora</creatorcontrib><creatorcontrib>Surenkok, Serdar</creatorcontrib><creatorcontrib>Oysul, Kaan</creatorcontrib><creatorcontrib>Dirican, Bahar</creatorcontrib><title>Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy</title><title>Tumori</title><description>Aims and Background The aim of the study was to evaluate the feasibility, toxicity and effectiveness of active breathing control-guided stereotactic body radiotherapy in the management of pulmonary oligometastases. Methods and Study Design Between June 2010 and June 2012, 20 patients (13 males, 7 females) with 31 pulmonary metastases referred to the Department of Radiation Oncology, Gulhane Military Medical Academy were treated using active breathing control-guided stereotactic body radiotherapy. Response Evaluation Criteria in Solid Tumors and Common Terminology Criteria for Adverse Events were used in the assessment of treatment response and toxicity, respectively. Results Assessment of treatment response revealed complete response, partial response, stable disease, and progressive disease in 30%, 25%, 30%, and 15% of the patients, respectively. At a median follow-up of 14 months, local control was 85% and overall survival was 70%, with negligible treatment-related toxicity. Conclusions Stereotactic body radiotherapy is safe and effective in the management of pulmonary oligometastases. It offers favorable treatment outcomes as a viable non-invasive therapeutic modality.</description><issn>0300-8916</issn><issn>2038-2529</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EEqHwA6z8A6Fj52FnCRWPSkVFPNaR7UxKqiSubHeRv8dR2SExGmk294zuvYTcMrhjTIglZACyYiXLGcThDM5IwiGTKS94dU6SWZDOikty5f0eIAdelglZv6pR7XDAMVDb0rdjP9hRuYlu-25nBwzKx0VP9UQ_Ajq0QZnQGfpgm4m-q6az4RudOkzX5KJVvceb37sgX0-Pn6uXdLN9Xq_uN6nhUoRUCC1YWXEjdVsVJssarnSrDGIuc2hAFrlqZIUy1zFGiSWCEFg0hQaoNJfZgvDTX-Os9w7b-uC6IVquGdRzGfXfMiK0PEE-hq339ujG6PE_4gf4OF-A</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Gamsiz, Hakan</creator><creator>Beyzadeoglu, Murat</creator><creator>Sager, Omer</creator><creator>Dincoglan, Ferrat</creator><creator>Demiral, Selcuk</creator><creator>Uysal, Bora</creator><creator>Surenkok, Serdar</creator><creator>Oysul, Kaan</creator><creator>Dirican, Bahar</creator><general>SAGE Publications</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140301</creationdate><title>Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy</title><author>Gamsiz, Hakan ; Beyzadeoglu, Murat ; Sager, Omer ; Dincoglan, Ferrat ; Demiral, Selcuk ; Uysal, Bora ; Surenkok, Serdar ; Oysul, Kaan ; Dirican, Bahar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gamsiz, Hakan</creatorcontrib><creatorcontrib>Beyzadeoglu, Murat</creatorcontrib><creatorcontrib>Sager, Omer</creatorcontrib><creatorcontrib>Dincoglan, Ferrat</creatorcontrib><creatorcontrib>Demiral, Selcuk</creatorcontrib><creatorcontrib>Uysal, Bora</creatorcontrib><creatorcontrib>Surenkok, Serdar</creatorcontrib><creatorcontrib>Oysul, Kaan</creatorcontrib><creatorcontrib>Dirican, Bahar</creatorcontrib><collection>CrossRef</collection><jtitle>Tumori</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gamsiz, Hakan</au><au>Beyzadeoglu, Murat</au><au>Sager, Omer</au><au>Dincoglan, Ferrat</au><au>Demiral, Selcuk</au><au>Uysal, Bora</au><au>Surenkok, Serdar</au><au>Oysul, Kaan</au><au>Dirican, Bahar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy</atitle><jtitle>Tumori</jtitle><date>2014-03-01</date><risdate>2014</risdate><volume>100</volume><issue>2</issue><spage>179</spage><epage>183</epage><pages>179-183</pages><issn>0300-8916</issn><eissn>2038-2529</eissn><abstract>Aims and Background The aim of the study was to evaluate the feasibility, toxicity and effectiveness of active breathing control-guided stereotactic body radiotherapy in the management of pulmonary oligometastases. Methods and Study Design Between June 2010 and June 2012, 20 patients (13 males, 7 females) with 31 pulmonary metastases referred to the Department of Radiation Oncology, Gulhane Military Medical Academy were treated using active breathing control-guided stereotactic body radiotherapy. Response Evaluation Criteria in Solid Tumors and Common Terminology Criteria for Adverse Events were used in the assessment of treatment response and toxicity, respectively. Results Assessment of treatment response revealed complete response, partial response, stable disease, and progressive disease in 30%, 25%, 30%, and 15% of the patients, respectively. At a median follow-up of 14 months, local control was 85% and overall survival was 70%, with negligible treatment-related toxicity. Conclusions Stereotactic body radiotherapy is safe and effective in the management of pulmonary oligometastases. It offers favorable treatment outcomes as a viable non-invasive therapeutic modality.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1177/030089161410000210</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-8916
ispartof Tumori, 2014-03, Vol.100 (2), p.179-183
issn 0300-8916
2038-2529
language eng
recordid cdi_crossref_primary_10_1177_030089161410000210
source Sage Journals Online
title Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A00%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Pulmonary%20Oligometastases%20by%20Stereotactic%20Body%20Radiotherapy&rft.jtitle=Tumori&rft.au=Gamsiz,%20Hakan&rft.date=2014-03-01&rft.volume=100&rft.issue=2&rft.spage=179&rft.epage=183&rft.pages=179-183&rft.issn=0300-8916&rft.eissn=2038-2529&rft_id=info:doi/10.1177/030089161410000210&rft_dat=%3Csage_cross%3E10.1177_030089161410000210%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c287t-77b71692c8bf95c33d2abfacee4840d0854ad89e84b0216e6e077e5d5b009b283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_sage_id=10.1177_030089161410000210&rfr_iscdi=true